{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":30,"n_cols":5,"rows_kept":30,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[8,2,8,3],[9,2,9,3],[12,2,12,3],[12,4,12,5],[13,2,13,3],[13,4,13,5],[14,2,14,3],[14,4,14,5],[15,2,15,3],[16,2,16,3],[19,2,19,3],[20,2,20,3],[21,2,21,3],[23,2,23,3],[24,2,24,3],[28,2,28,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISA996294050203316"]
[null,null,"Titolo",null,"APL bioengineering"]
[null,null,"Pubbl/distr/stampa",null,"Melville, NY : , : AIP Publishing, , [2017-]"]
[null,null,"Descrizione fisica",null,"1 online resource"]
[null,null,"Disciplina",null,"660.6"]
[null,null,"Soggetti",null,"Bioengineering"]
[{"$nulls":4},"Periodical"]
[{"$nulls":4},"Periodicals."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Periodico"]
[null,null,null,"Note generali","Refereed/Peer-reviewed"]
[null,"2.","Record Nr.",null,"UNINA9910781094403321"]
[null,null,"Autore",null,"Teoh Gerrard"]
[null,null,"Titolo",null,"Towards individualized therapy for multiple myeloma [[electronic resource] ] : a guide for choosing treatment that best fits patients / / Gerrard Teoh"]
[null,null,"Pubbl/distr/stampa",null,"Singapore ; ; Hackensack, NJ, : World Scientific Publishing Co., c2009"]
[null,null,"ISBN",null,"1-282-44261-9"]
[{"$nulls":4},"9786612442612"]
[{"$nulls":4},"981-283-580-6"]
[null,null,"Descrizione fisica",null,"1 online resource (201 p.)"]
[null,null,"Disciplina",null,"616.9941806"]
[null,null,"Soggetti",null,"Multiple myeloma"]
[{"$nulls":4},"B cells - Tumors"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Prologue; CONTENTS; Chapter 1. Introduction; Chapter 2. Diagnostic Dilemmas; Chapter 3. Shortcomings of Modern-Day Clinical Trials; Chapter 4. Individualizing Core Parameters; Chapter 5. Patient Compliance; Chapter 6. Multiple Myeloma; Chapter 7. Current Treatment; Chapter 8. Future Opportunities; Chapter 9. Concluding Remarks; Abbreviations; Glossary; List of Figures; List of Tables; References; Index"]
[null,null,null,"Sommario/riassunto","This very provocative book takes the reader on a \"think-out-of-the-box\" journey through the development of a treatment regimen for multiple myeloma called \"dtZ\". It is a firsthand account of how more than 50 patients with myeloma were given a non-toxic, precisely-targeted, anti-cancer treatment that was specifically adapted to their individual cancers. These Individualized Anti-Cancer Targeted Therapies (smart bombs) have produced amongst the best responses as well as survival rates for myeloma. Accordingly, the author argues that some patients might even have been \"cured\" of their cancers. Th"]